Quick Facts: Uses and Benefits

• Addresses: Calcium and Vitamin D deficiencies
• Support: Bone mineral maintenance and health
• Application: Adjunctive treatment for osteoporosis

Orocal Vitamine D3 is a combined therapeutic option used to address deficiencies in calcium and Vitamin D, which are necessary for maintaining proper bone metabolism. This established treatment is indicated for the prevention and management of these deficiencies, particularly in elderly patients where intake may be insufficient.

Its main clinical application is as an adjunctive treatment alongside other established therapies for osteoporosis, a condition characterized by reduced bone mass and increased risk of fractures. The active components support the body's ability to maintain adequate serum calcium levels and promote normal mineralization of bone tissue. These components play a role in supporting skeletal structure and function.

Who Can and Cannot Use Orocal Vitamine D3?

The eligibility profile for Orocal Vitamine D3 (Calcium Carbonate/Cholecalciferol) is defined by official regulatory documentation, focusing on absolute contraindications and restrictions related to calcium and Vitamin D levels, as well as kidney function.

---

Contraindications (Must Not Use)

Individuals are contraindicated if they have:

• Hypersensitivity (allergy) to the active substances or any component of the medicine.
• Hypercalcaemia (abnormally high blood calcium) or Hypercalciuria (excessive urinary calcium excretion).
• Hypervitaminosis D (excessive Vitamin D levels).
• Severe Renal Impairment or a history of calcium-containing kidney stones (calcium lithiasis).

---

Restrictions and Limitations

Population/Condition	Eligibility Status	Key Restriction
Children & Adolescents	Not Recommended	Use is often restricted or not approved below a certain age (e.g., under 12 years).
Pregnancy & Lactation	Permitted (Conditional)	Use is allowed, but total daily intake of calcium and Vitamin D from all sources must not exceed specified regulatory limits.
Renal Impairment	Conditional Use	Patients with mild to moderate kidney issues require careful supervision and regular monitoring of calcium levels.
Sarcoidosis	Conditional Use	Requires caution due to an increased risk of hypercalcaemia in this condition.

Eligibility is defined by excluding populations where the drug's components could cause harm by elevating already high levels or compromising damaged kidneys.

Interactions with other medicines and products

The interaction profile for this combination product of Calcium Carbonate and Cholecalciferol (Vitamin D3) is documented by regulatory authorities and centers on altered absorption and combined physiological effects.

Pharmacodynamic and Metabolic Interactions

Interacting Substance Category	Formal Interaction Outcome
Cardiac Glycosides (e.g., Digoxin)	Increased risk of toxicity, as hypercalcaemia may potentiate arrhythmogenic effects.
Thiazide Diuretics	Increased risk of hypercalcaemia due to reduced urinary calcium excretion.
Anticonvulsants (e.g., Phenytoin, Barbiturates)	Decreased Vitamin D activity due to increased metabolic catabolism.
Corticosteroids	Reduced calcium absorption, potentially decreasing the product's effect.

Physicochemical Absorption Interference and Timing Rules

The calcium component interferes with the gastrointestinal absorption of several co-administered medicines, necessitating specific time separation rules:

• Tetracycline and Quinolone Antibiotics have their absorption reduced; administration must be separated by several hours (two before or four to six after).
• Levothyroxine (Thyroid Hormones) and Bisphosphonates also require administration to be separated by at least three to four hours from the calcium dose to prevent reduced efficacy of the co-administered drug.
• Iron, Zinc, and Strontium supplements require a two-hour separation period.

Interactions with food include a warning that Oxalic Acid (e.g., in spinach) and Phytic Acid (e.g., in whole grains) can inhibit calcium absorption if consumed within a two-hour period of dosing.

How Orocal Vitamine D3 Works

Activating Transcriptional Machinery for Absorption

This domain details the molecular role of Cholecalciferol, which is metabolically activated to an agonist of the Vitamin D Receptor (VDR), a nuclear transcription factor. VDR activation leads to the upregulation of key intestinal calcium transport proteins (like TRPV6 and Calbindin-D9k), initiating the biological capacity to facilitate the transepithelial movement of calcium from the gut lumen into the bloodstream.

Synergistic Coupling of Substrate and Regulator

The effect relies on the mechanistic synergy between the two components. Cholecalciferol provides the regulatory drive by building the transport capacity, while Calcium Carbonate provides the Ca^2+ substrate for that upregulated machinery to process. This co-dependence allows for the coordinated processing of mineral input and biological capacity for absorption, which establishes the mechanism for net transfer of calcium across the intestinal barrier.

️ Systemic Homeostasis and Feedback Modulation

The resulting increase in systemic Ca^2+ levels triggers a negative feedback loop via the CaSR on the parathyroid glands. This action helps stabilize the extracellular mineral concentration and leads to the appropriate suppression of Parathyroid Hormone (PTH) release. This systemic stabilization establishes the necessary plasma Ca^2+ concentration for subsequent physiological utilization, including skeletal matrix formation.

How to Use Orocal Vitamine D3

Orocal Vitamine D3 is intended for oral administration as a fixed-dose combination of calcium carbonate and cholecalciferol (Vitamin D3). The medicine is typically available as a chewable tablet, which is fully chewed or sucked before swallowing. The administration is flexible regarding food and time of day, as it may be taken at any time, with or without a meal.

The regimen for adults and the elderly often involves a daily intake equivalent to 1000 mg of elemental calcium and between 800 IU to 1000 IU of Vitamin D3. This dosage is achieved through a once-daily schedule using specific high-strength formulations, or via divided dosing (such as twice daily) when using lower-strength tablets.

A critical instruction for proper use involves the separation of intake from other oral medications. To prevent interference with absorption, this medicine is taken at a specific distance from agents such as bisphosphonates, tetracycline antibiotics, quinolone antibiotics, or levothyroxine.

Usage is intended as part of a long-term treatment plan. Because of this, continuous administration requires periodic monitoring of calcium levels in both the blood and urine, as well as the assessment of kidney function. The product should not be used in patients diagnosed with severe renal impairment. While the standard adult dose applies to the elderly, the medicine is not generally intended for use in the paediatric population.

Research Evidence / Overview of Studies for Orocal Vitamine D3

Evidence for Use in Preventing and Treating Calcium and Vitamin D Deficiency

Studies explored the combination in populations with documented low levels of Vitamin D and calcium. These studies typically include short-term and intermediate-term Randomized Controlled Trials (RCTs) and various observational studies. Studies examined measurements of key markers, such as serum 25-hydroxyvitamin D concentration and serum calcium levels, in populations taking the combination.

The studies focused primarily on older adults, including those who were institutionalized or had documented low baseline Vitamin D levels. Findings describe patterns observed in the studies related to the changes in these nutritional markers measured during the study period. Studies monitored these outcomes over intervals ranging from a few months up to a year. The evidence contributes to the broader research landscape regarding these deficiency markers.

Evidence for Use as a Supplement to Osteoporosis Treatment

This part of the overview describes the research that has explored the use of this combination when it is added to existing treatments for osteoporosis. The research structure includes large-scale RCTs and pooled analyses. These studies focused on populations at high risk, such as post-menopausal women with established osteoporosis, and studies monitored structural and functional bone outcomes.

The primary outcomes research examined included the frequency of incident hip fractures and non-vertebral fractures over time. Research also monitored measurements of Bone Mineral Density (BMD) at the hip and spine. The research examined the frequency of fracture events in the study populations, which required follow-up durations of two to three years. The findings describe how fracture event frequency was tracked in the observed groups in the research.

Long-Term Studies and Follow-Up Data

When considering the long-term data, research explored the durability of changes over defined time intervals. The typical follow-up duration in the major RCTs for fracture outcomes was up to approximately three years. This means there is limited information for long-term outcomes, and certainty remains low regarding effects that extend significantly beyond this period. Research provides insight into short-term changes, but information regarding the duration of changes to bone health and fracture risk over many years is not fully established.

What is Still Uncertain About Orocal Vitamine D3 Research

While studies contribute to the broader evidence landscape, there are still areas where research is ongoing. Evidence quality varies across studies, and some key limitations persist. Follow-up durations were defined in many studies focused on fracture risk. Additionally, findings were mixed or inconsistent across different trials. Comparative evidence is lacking to understand how this product was studied against every other type of calcium or Vitamin D supplement available. Ultimately, evidence highlights what is known and what is still uncertain.

Key Studies & References

1. Public Assessment Report Scientific discussion Calcium and Vitamine D3 Alpex 1000 mg/880 IE, effervescent granules (Regulatory Document for established use)
2. Section 5: Non-pharmacological management of osteoporosis | National Osteoporosis Guideline Group (NOGG)

Common questions about Orocal Vitamine D3 (FAQ)

---

Q: What is the main difference between Orocal Vitamine D3 and a standard calcium supplement?

Orocal Vitamine D3 is a fixed-dose combination product, which means it contains two active ingredients: calcium and cholecalciferol (Vitamin D3). Official product information highlights that the Vitamin D3 component is necessary to effectively regulate and enhance the body's absorption of the calcium in the intestine, a function that relies on both components, unlike calcium-only supplements.

---

Q: Can Orocal Vitamine D3 cause constipation, and if so, how is it managed?

Regulatory documents classify constipation as a rare adverse reaction associated with this medication. While official product information identifies this potential side effect, it does not provide specific non-medical advice on management. Management of this rare symptom should be discussed with a healthcare professional.

---

Q: What is the source of the Vitamin D3 in Orocal Vitamine D3?

The product contains cholecalciferol, which is a synthesized or derived form of Vitamin D3. While the product label identifies the chemical form, the specific commercial or natural source material used in its industrial preparation is not typically specified in the patient regulatory information.

---

Q: What is the difference between Orocal Vitamine D3 and just getting enough sun?

The cholecalciferol in this medication is the same active form of Vitamin D3 that your body produces when exposed to sunlight. Taking the oral supplement is intended to provide this vitamin to help maximize the absorption of the calcium component, which supports the dietary need when sun exposure is insufficient.

---

Q: Is the calcium in Orocal Vitamine D3 easily absorbed by the body?

The product is designed to promote absorption. The Vitamin D3 component is crucial because it helps to regulate and significantly increase the body's natural capacity to transfer the calcium from the digestive system into the bloodstream, which is intended to optimize the intestinal uptake of calcium.

---

Q: Is the calcium in Orocal Vitamine D3 considered elemental calcium?

Yes, the calcium in the product is provided as Calcium Carbonate. Regulatory documents specify the amount of elemental calcium contained within the tablet (for example, 1250 mg of Calcium Carbonate is equivalent to 500 mg of elemental calcium), which represents the amount available for the body to utilize.

---

Q: Is it normal to feel slightly nauseous when first starting Orocal Vitamine D3?

Nausea is listed in the official safety text as a rare adverse reaction associated with this medication. Any persistent or severe nausea should be brought to the attention of a healthcare professional.

---

Q: Are there any specific foods that should be avoided while taking this medication?

Official information advises separating the intake of this medicine from foods containing large amounts of oxalic acid (found in spinach, rhubarb, tea, cocoa) or phytic acid (found in wholemeal cereals and seeds). Intake should be separated from these foods by a few hours, as they can reduce calcium absorption.

---

Q: Can Orocal Vitamine D3 be taken with antacids for heartburn relief?

Specific timing separation may be required for antacids containing ingredients like magnesium or aluminum to avoid absorption interference. The calcium component itself also has mild antacid properties, and the product label should be consulted for specific timing rules.

---

Q: Do I need to take Orocal Vitamine D3 with a meal, or can I take it on an empty stomach?

According to the official product information, the administration of the tablet is highly flexible. The medicine can be taken at any time, with or without food.

---

Q: Is there a generic version of Orocal Vitamine D3 available?

Regulatory and national drug databases often list combination products containing the same active ingredients, Calcium Carbonate and Colecalciferol, by other manufacturers. These similar formulations, based on the same active ingredients, are often referred to as generic equivalents.

---

Q: Has Orocal Vitamine D3 been studied in post-menopausal women specifically?

Studies supporting the product's use often include populations at high risk for bone loss, such as post-menopausal women. Official product indications for use include supplementary treatment for osteoporosis, a condition common in this group.

---

Q: Can Orocal Vitamine D3 cause dry mouth or increased thirst?

Dry mouth and increased thirst are not listed as common side effects of the product. However, these symptoms are recognized signs associated with hypercalcemia (abnormally high calcium levels), which is listed as an uncommon adverse reaction. Such symptoms warrant evaluation by a healthcare professional.

---

Q: Why do some people take Orocal Vitamine D3 for osteoporosis prevention?

The product is officially indicated for the treatment of calcium and Vitamin D deficiency and is used as a supplement to specific drug treatments for osteoporosis. By addressing deficiencies, the combination supports the essential mineral balance and bone metabolism.

---

Q: Is Orocal Vitamine D3 suitable for individuals who are lactose intolerant?

Suitability depends on the presence of lactose or dairy derivatives among the inactive ingredients (excipients). To determine this, official patient information requires checking the full excipient list on the label, which details all non-active components.

---

Q: Can I crush the Orocal Vitamine D3 tablet if I have trouble swallowing pills?

The tablets are specifically designed as chewable tablets. Official instructions state that the tablets must be fully chewed or sucked before swallowing, as swallowing them whole is not the method of administration specified in the product information.

---

Q: Can the flavoring or sweeteners in Orocal Vitamine D3 cause side effects?

Regulatory documents list excipients such as sucrose and isomalt, which are used for flavoring and texture. These inactive ingredients carry special warnings for patients with certain conditions like hereditary fructose intolerance or diabetes.

---

Q: Why is consistency in taking Orocal Vitamine D3 important for bone density?

The medicine is intended for long-term treatment. Consistency is important because the function relies on the continuous presence of Vitamin D3 to upregulate the calcium absorption machinery, which is necessary for the continuous maintenance of stable mineral levels that support bone health.

---

Q: Does Orocal Vitamine D3 have an expiration date I should watch out for?

Yes, regulatory documents define a clear shelf-life (expiration date) for the product. The official instructions provide details on the proper storage conditions and the necessary process for safely disposing of any expired medication.

---

Q: Are there any lifestyle changes that improve the effectiveness of Orocal Vitamine D3?

Official warnings about separating the intake of this medicine from certain medications and foods (like those containing oxalic or phytic acid) suggest that patient behavior can significantly affect its absorption. Adherence to these timing rules is important to maximize the product’s intended effectiveness.

---

Q: Can Orocal Vitamine D3 be used to address general Vitamin D deficiency?

The product is officially indicated for the treatment of combined Vitamin D and calcium deficiencies in the elderly. Its composition is designed to address both of these nutritional needs simultaneously.

---

Q: What is the recommended duration of treatment with Orocal Vitamine D3?

The product is intended as part of a long-term treatment plan to address chronic mineral deficiencies and bone health support. The specific duration of treatment is determined by the treating physician based on periodic monitoring of the patient's individual calcium and Vitamin D status.

---

Q: Is it better to take the Orocal Vitamine D3 tablet whole or can it be chewed?

The tablets are designated as chewable. Official regulatory instructions state that they must be fully chewed or sucked before swallowing, as swallowing them whole is not the specified method of administration.

How to Store and Dispose of Orocal Vitamine D3?

The storage requirements for Orocal Vitamine D3 are defined by regulatory documents to protect the stability of the active ingredients.

Official Storage Conditions

Requirement	Specific Condition
Temperature	Store below 25 C and do not freeze the tablets.
Protection	Must be protected from light and moisture.
Packaging	Keep the medicine in its original package and ensure the container is tightly closed.

Handling and Disposal

• Child Safety: The product must be stored out of the sight and reach of children.
• Disposal: Any unused or expired product must be discarded in accordance with local requirements for pharmaceutical waste.